myoblasts went through apoptosis with significant activation of caspase-3, associating hypoxia with cell death pathways in transplanted myoblasts. The identification of combinations of small molecules that overcome hypoxia-associated cell death might benefit the development of transplantation strategies for patients with skeletal muscle degenerative diseases. In this study, the exposure of myoblasts to 0.1 hypoxia for five days was devised as in vitro condition to induce hypoxia-induced cell death/growth arrest. While the culture of myoblasts in vitro may result in adapted nutrient availability and metabolism, these cells are nonetheless able to Apremilast proliferate more Letermovir rapidly under normoxic rather than hypoxic conditions . Another aspect to consider is that cells might adapt to anaerobic metabolism during hypoxia, resulting in glycolysis and lactic acidosis . However, altered metabolisms are considered as a part of the hypoxic phenomena. Further studies are needed to determine what aspects of hypoxia- induced cellular damage our candidate factors specifically protect the cells from, including but not limited to metabolic perturbations. Herein, five potent kinase inhibitors that protect myoblasts from hypoxia-induced death/ growth arrest were identified. Among the intracellular targets, cell cycle kinases were shown to play key roles and growing evidence suggests that they are linked with hypoxia-induced cell death . Upon hypoxia exposure, cells activate the DNA Damage Response , mediated by ATM, ATR, CHK1 and CHK2 , key controllers of cell cycle checkpoint pathways . One of the main regulators of CDKs expression, Notch, has also been reported to play an important role in the response to hypoxia and is a critical regulator of cell fate decisions in muscle progenitors . Additionally it has been shown that upon hypoxia another cell cycle regulatory kinase, WEE1, a target of the most efficient inhibitor P17, is rapidly activated . WEE1 is a tyrosine kinase that phosphorylates cdc25 at the G2/M checkpoint and prevents the progression to mitosis . The targets of G13, the second most effective inhibitor, are JAK2 and JAK3, which have been reported to influence CDKs and Glyc